Amgen Inc (AMGN)
270.90
+2.03
(+0.76%)
USD |
NASDAQ |
Mar 18, 16:00
270.91
+0.01
(+0.00%)
After-Hours: 06:41
Amgen Price to Book Value: 23.30 for March 18, 2024
Price to Book Value Chart
Historical Price to Book Value Data
Date | Value |
---|---|
March 18, 2024 | 23.30 |
March 15, 2024 | 23.12 |
March 14, 2024 | 23.35 |
March 13, 2024 | 23.73 |
March 12, 2024 | 23.78 |
March 11, 2024 | 23.68 |
March 08, 2024 | 23.54 |
March 07, 2024 | 23.46 |
March 06, 2024 | 23.79 |
March 05, 2024 | 23.79 |
March 04, 2024 | 24.03 |
March 01, 2024 | 24.11 |
February 29, 2024 | 23.55 |
February 28, 2024 | 23.86 |
February 27, 2024 | 23.95 |
February 26, 2024 | 24.63 |
February 23, 2024 | 24.87 |
February 22, 2024 | 24.52 |
February 21, 2024 | 24.38 |
February 20, 2024 | 24.38 |
February 16, 2024 | 24.40 |
February 15, 2024 | 24.86 |
February 14, 2024 | 24.94 |
February 13, 2024 | 24.98 |
February 12, 2024 | 25.32 |
Date | Value |
---|---|
February 09, 2024 | 25.03 |
February 08, 2024 | 25.33 |
February 07, 2024 | 25.42 |
February 06, 2024 | 27.15 |
February 05, 2024 | 27.66 |
February 02, 2024 | 27.77 |
February 01, 2024 | 27.88 |
January 31, 2024 | 27.00 |
January 30, 2024 | 27.03 |
January 29, 2024 | 26.93 |
January 26, 2024 | 26.78 |
January 25, 2024 | 26.65 |
January 24, 2024 | 26.25 |
January 23, 2024 | 26.62 |
January 22, 2024 | 26.65 |
January 19, 2024 | 26.44 |
January 18, 2024 | 26.16 |
January 17, 2024 | 26.12 |
January 16, 2024 | 26.07 |
January 12, 2024 | 26.33 |
January 11, 2024 | 26.04 |
January 10, 2024 | 26.17 |
January 09, 2024 | 26.40 |
January 08, 2024 | 26.71 |
January 05, 2024 | 26.03 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
9.181
Minimum
Mar 27 2019
149.73
Maximum
May 31 2022
25.98
Average
15.43
Median
Jan 27 2021
Price to Book Value Benchmarks
Gilead Sciences Inc | 3.997 |
Johnson & Johnson | 5.490 |
Eli Lilly and Co | 67.27 |
Merck & Co Inc | 8.184 |
Vertex Pharmaceuticals Inc | 6.040 |
Price to Book Value Related Metrics
PE Ratio | 21.69 |
PS Ratio | 5.168 |
PEG Ratio | 6.912 |
Price to Free Cash Flow | 19.80 |
Price | 270.90 |
Earnings Yield | 4.61% |
Market Cap | 145.18B |
PEGY Ratio | 3.428 |
Operating PE Ratio | 18.45 |
Normalized PE Ratio | 21.69 |